Does CEMIPLIMAB Cause Off label use? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Off label use have been filed in association with CEMIPLIMAB (LIBTAYO). This represents 3.4% of all adverse event reports for CEMIPLIMAB.
35
Reports of Off label use with CEMIPLIMAB
3.4%
of all CEMIPLIMAB reports
11
Deaths
19
Hospitalizations
How Dangerous Is Off label use From CEMIPLIMAB?
Of the 35 reports, 11 (31.4%) resulted in death, 19 (54.3%) required hospitalization, and 3 (8.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEMIPLIMAB. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does CEMIPLIMAB Cause?
Fatigue (68)
Pyrexia (49)
Pneumonia (41)
Dyspnoea (40)
Pneumonitis (38)
Diarrhoea (34)
Rash (34)
Cytokine release syndrome (33)
Pain (33)
Asthenia (32)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CEMIPLIMAB Alternatives Have Lower Off label use Risk?
CEMIPLIMAB vs CEMIPLIMAB-RWLC
CEMIPLIMAB vs CENEGERMIN-BKBJ
CEMIPLIMAB vs CENOBAMATE
CEMIPLIMAB vs CEPHALEXIN
CEMIPLIMAB vs CERITINIB